Press Releases

Rigel Announces Departure of Chief Financial Officer

Dec 15, 2017 7:30am EST

Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Dec 08, 2017 7:05pm EST

Rigel to Present One-Year Efficacy and Safety Results for Fostamatinib in ITP at the 2017 American Society of Hematology Annual Meeting

Dec 08, 2017 7:30am EST

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Nov 17, 2017 4:05pm EST

Rigel Announces Third Quarter 2017 Financial Results and Provides Company Update

Nov 07, 2017 4:01pm EST

Rigel Welcomes Gregg Lapointe to Board of Directors

Nov 02, 2017 7:30am EDT

Rigel Announces Conference Call and Webcast to Report Third Quarter 2017 Financial Results

Oct 31, 2017 7:30am EDT

Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares

Oct 10, 2017 4:01pm EDT

Rigel Announces Pricing Of Public Offering Of Common Stock

Oct 04, 2017 10:36pm EDT

Rigel Announces Proposed Public Offering Of Common Stock

Oct 03, 2017 4:01pm EDT